Neurological rehabilitation therapists support recovery and adaptation in individuals affected by brain or spinal cord injury, stroke, or chronic neurological diseases. Their practice spans physical, occupational, and speech therapies, targeting motor skills, communication, and daily living functions. Through repetitive training and adaptive strategies, they promote neuroplasticity and help patients regain independence in mobility, coordination, and cognition. They assess each patient’s impairments and goals to design personalized treatment plans.
They collaborate closely with neurologists, physiatrists, psychologists, and caregivers to ensure a holistic approach to rehabilitation. Neurological rehabilitation therapists also play a crucial role in psychosocial adjustment, pain management, and return-to-work programs. Many engage in research on functional recovery, assistive devices, and robotics-based therapies. Their expertise enhances patients’ quality of life and reduces long-term disability, making them integral to the continuum of neurological care. Their dedication transforms clinical recovery into meaningful reintegration into society.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom